Sturge-Weber Syndrome
Neurol 55:1472-1479, Arzimanoglou,A.A.,et al, 2000
Subarachnoid Haemorrhage Treated with Anticoagulants
Lancet 356:1818, Ciccone,A.,et al, 2000
Intrathecal Methylprednisolone for Intractable Postherpetic Neuralgia
NEJM 343:1514-1519,1563, Kotani,N.,et al, 2000
Selegiiline and Mortality in Subjects with Parkinson's Disease
Neurol 55:1785-1789,1770, Donnan,P.T.,et al, 2000
When Drugs Don't Work
Neurol 55:1780-1784, Benbadis,S.R.,et al, 2000
Prolongation of Midazolam Half-Life After Sustained Infusion for Status Epilepticus
Neurol 54:1366-1368, Naritoku,D.K.&Sinha,S., 2000
Intravenous Valproate in Pediatric Epilepsy Patients with Refractory Status Epilepticus
Neurol 54:2188-2189, Uberall,M.A.,et al, 2000
Long-Term Follow-Up of Unilateral Pallidotomy in Advanced Parkinson's Disease
NEJM 342:1708-1714, Fine,J.,et al, 2000
Dopamine Agonists: Their Role in the Treatment of Parkinson's Disease
JNNP 68;685-690, Brooks,D.J., 2000
Association Between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
NEJM 342:1560-1567, Lucking,C.B.,et al, 2000
Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease
JAMA 283:2674-2679, Ross,G.W.,et al, 2000
Depression in Parkinson's Disease
BMJ 320:1287-1288, Allain,H.,et al, 2000
Intracerebral Haemorrhage in Young Adults: The Emerging Importance of Drug Misuse
BMJ 320:1322-1324, McEvoy,A.W.,et al, 2000
Clinical Characteristics of Pramipexole-Induced Peripheral Edema
Arch Neurol 57:729-732, Tan,E.K.&Ondo,W., 2000
Axial Parkinsonian Symptoms Can Be Improved: The Role of Levodopa and Bilateral Subthalamic Stimulation
JNNP 68:595-600, Bejjani,B.P.,et al, 2000
Quetiapine for L-Dopa-Induced Psychosis in PD
Neurol 54:1538, Weiner,W.J.,et al, 2000
A Five-Year Study of the Incidence of Dyskinesia in Patients With Early Parkinson's Disease who were Treated with Ropinirole or Levodopa
NEJM 342:1484-1491, Rascol,O.,et al, 2000
Idiopathic Stabbing Headache Associated With Monocular Visual Loss
Arch Neurol 57:745-746, Ammache,Z.,et al, 2000
The Catechol-O-Methyltransferase (COMT) Inhibitor Entacapone Enhances the Pharmacokinetic and Clinical Response to Sinemet CR in Parkinson's Disease
JNNP 68:589-594, Piccinni,P.,et al, 2000
Structural Changes of the Substantia Nigra in Parkinson's Disease as Revealed by MR Imaging
AJNR 21:697-701, Hutchinson,M.&Raff,U., 2000
Functional Outcomes After Gamma Knife Thalamotomy for Essential Tremor and MS-Related Tremor
Neurol 55:443-446, Niranjan,A. et al, 2000
A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor
NEJM 342:461-468,505, Schuurman,P.R.,et al, 2000
Driving in Adults with Refractory Localization-Related Epilepsy
Neurol 54:625-630, Berg,A.T.,et al, 2000
Objective Changes in Motor Function During Placebo Treatment in PD
Neurol 54:710-714, Goetz,C.G.,et al, 2000
Effects of Bilateral Posteroventral Pallidotomy on Gait of Subjects with Parkinson Disease
Arch Neurol 57:198-204, Siegel,K.L.&Metman,L.V., 2000
Striatal Dopamine Trnasporter Binding Assessed by [I-123]IPT and Single Photon Emission Computed tomography in Patients with Early Parkinson's Disease, Implications for a Preclinical Diagnosis
Arch Neurol 57:205-208, Schwarz,J.,et al, 2000
The Nonmotor Problems of Parkinson's Disease
The Neurologist 6:18-27, Friedman,J.H.&Fernandez,H.H., 2000
Tolcapone and Hepatotoxic Effects
Arch Neurol 57:263-267, Olanow,C.W.&Tasmar Advisory Panel, 2000
New Drugs:Which Should Be Included in the Formulary?, Epilepsy:All New Drugs Should Be Included
Arch Neurol 57:272-273,275, Pierre-Louis,S.J.C., 2000
Restrictions on the Availability of Antiepileptic Drugs
Arch Neurol 57:273-274,275, Bergen,D.C., 2000
Early Identification of Refracvtory Epilepsy
NEJM 342:314-319, Kwan,P.&Brodie,M.J., 2000
Language Disturbances in Corticobasal Degeneration
Neurol 54:990-992, Frattali,C.M.,et al, 2000
The Evolution of Diagnosis in Early Parkinson Disease
ArchNeurol 57:369-372, Jankovic,J.,et al, 2000
Vagus Nerve Stimulation Therapy for Epilepsy in Older Adults
Neurol 54:1179-1182, Sirven,J.I.,et al, 2000
Tourette's Syndrome Improvement with Pergolide in a Randomized, Double-Blind, Crossover Trial
Neurol 54:1310-1315, Gilbert,D.L.,et al, 2000
Progression of Parkinsonian Signs in Alzheimer's Disease
Neurol 54:1284-1289, Wilson,R.S.,et al, 2000
Botulinum Toxin A as Treatment for Drooling Saliva in PD
Neurol 54:244-247, Pal,P.K.,et al, 2000
Management of Epilepsy in Adolescents and Adults
Lancet 356:323-329, Brodie,M.J. & French,J.A., 2000
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Deep Brain Stimulation of Subthalamic Area for Severe Proximal Tremor
Neurol 55:114-116, Kitagawa,M. et al, 2000
Surgery for Parkinson Disease
Arch Neurol 57:1118-1125, Lang,A.E., 2000
Health-Related Quality of Life in Neurology
Arch Neurol 57:1224-1227, Meyers,A.R. et al, 2000
The Brain lesion Responsible for Parkinsonism After Carbon Monoxide Poisnoning
Arch Neurol 57:1214-1218, Sohn,Y.H. et al, 2000
Pallidal Stimulation for Generalized Dystonia
J Neurosurg 92:453-456, Tronnier,V.M. &Fogel,W., 2000
Niemann-Pick Disease Type C: Two Cases and an Update
Movement Disorders 15:1199-1203, Uc,E.Y.,et al, 2000
Neurosyphilis as a Cause of Facial and Vestibulocochlear Nerve Dysfunction: MR Imaging Features
AJNR 21:1673-1675, Smith, M.M. & Anderson, J.C., 2000
Headache: Cortical Vein Thrombosis and Response to Anticoagulation
J Emerg Med 17:449-453, Minadeo,J.P &Karaman,B.A., 1999
Dementia Following Treatment of Brain Tumors with Radiotherapy Administered Alone or in Combination with Nitrosourea-Based Chemotherapy: A Clinical and Pathological Study
J Neurooncol 41:137-149, Vigliani,M.C.,et al, 1999
Delayed Movement Disorders After Carbon Monoxide Poisoning
Eur Neurol 42:141-144, Choi,I.S. &Cheon,H.Y., 1999
Botulinum Toxin is a Useful Treatment in Excessive Drooling of Saliva
JNNP 67:697, Bhatia,K.P.,et al, 1999